NEWS
Apr 13, 2021
Actimed Therapeutics and Faraday Pharmaceuticals Announce License Agreement for S-oxprenolol
Feb 2, 2021
Actimed Therapeutics Appoints Frank Misselwitz MD, PhD as Chief Medical Officer
Management Team and Board